Roche Diagnostics Hematology, Inc.
USPTO PatentsView assignee record - 39 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).
The verdict
According to USPTO PatentsView, Roche ranks #8,278 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 10 technology areas.
- #8,278
- of 49,997 US assignees by volume
- Top 39%
- by Innovation Score (39.1/100)
- 22.0
- avg claims per patent
- -73%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R8278 · US Corporation #8,278 · 39 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 39 grants
- UPPER-Q #8,278/49,997
- PHOTO-FINISH Radiation Monitoring…
- CPC-FOCUS G01N · 10 areas
- INNOV-THIN 39.1/100
- CLAIMS-DENSE 22.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -73% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Radiation Monitoring Devices, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Roche’s 39.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Roche
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Jiangsu Hecheng… · near
Jiangsu Hecheng… · near
39 score
- Raycan Technology… · near
Raycan Technology… · near
39 score
- Roche Diagnostics… · this assignee
Roche Diagnostics… · this assignee
39 score
- Snipr · near
Snipr · near
39 score
- Suven Life Sciences · near
Suven Life Sciences · near
39 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Roche's Innovation Score is 39.1/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Roche?
Each dot is one of Roche’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Roche’s own 22.0 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Roche's grants concentrate
Roche Diagnostics Hematology, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 84.6% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2015 (10 grants) versus a trough of 1 in 2022. By volume, Roche sits between Realwear, Inc. and Shenzhen Bestqi Innovation Technology Co., Ltd.
Roche's three-year grant acceleration
Roche Diagnostics Hematology, Inc. shows 3 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Roche's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Realwear
Realwear, Inc.
39 patents
- Radiation Monitor…
Radiation Monitoring Devices, Inc.
39 patents
- Rawles
Rawles LLC
39 patents
- Reliance Jio Info…
Reliance Jio Infocomm Limited
39 patents
- Shanghai Harvest…
Shanghai Harvest Intelligence Technology Co., Ltd
39 patents
- Shanghai Institut…
Shanghai Institute OF Ceramics, Chinese Academy OF Sciences
39 patents
- Shenyang Institut…
Shenyang Institute OF Automation, Chinese Academy OF Sciences
39 patents
- Shenzhen Bestqi I…
Shenzhen Bestqi Innovation Technology Co., Ltd
39 patents
- Roche Diagnostics… ◀
Roche Diagnostics Hematology, Inc.
39 patents
What this shows Roche holds 39 patents at rank #8,277, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Roche
By rank, the assignees closest to #8,277 in granted patent volume.
- Realwear, Inc. #8,273 · 39 patents
- Radiation Monitoring Devices, Inc. #8,274 · 39 patents
- Rawles LLC #8,275 · 39 patents
- Reliance Jio Infocomm Limited #8,276 · 39 patents
- Shanghai Harvest Intelligence Technology Co., Ltd #8,278 · 39 patents
- Shanghai Institute OF Ceramics, Chinese Academy OF Sciences #8,279 · 39 patents
- Shenyang Institute OF Automation, Chinese Academy OF Sciences #8,280 · 39 patents
- Shenzhen Bestqi Innovation Technology Co., Ltd #8,281 · 39 patents
Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)
Other assignees with the most granted patents in Roche's primary technology class.
- The Regents of the University of California 1,153 in class
- Shimadzu Corporation 1,111 in class
- Saudi Arabian OIL Company 837 in class
- Halliburton Energy Services, Inc. 816 in class
- The Boeing Company 701 in class
- General Electric Company 634 in class
- Kla-tencor Corporation 583 in class
- Massachusetts Institute of Technology 530 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Roche, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Roche ranks #457 of 7,863 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (39 here).
Roche's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
39 Top 39% higher than 61% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 25.6% |
| 2016 | 4 | 10.3% |
| 2017 | 7 | 17.9% |
| 2018 | 4 | 10.3% |
| 2019 | 5 | 12.8% |
| 2020 | 3 | 7.7% |
| 2021 | 2 | 5.1% |
| 2022 | 1 | 2.6% |
| 2024 | 2 | 5.1% |
| 2025partial year | 1 | 2.6% |
Which technologies does Roche Diagnostics Hematology, Inc. patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Roche Diagnostics Hematology, Inc.'s patent record in context - here's where to go next.
- Roche Diagnostics Hematology, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 84.6% of its portfolio - see every assignee active in that class. Explore G01N
- Ranked #8,278 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Roche Diagnostics Hematology, Inc. against Realwear, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.